Glucocorticoids induce G1 cell cycle arrest in human neoplastic thymic epithelial cells

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 5, 2005, Pages 314-322

  Funakoshi, Yasunobu ^a   Shiono, Hiroyuki ^a   Inoue, Masayoshi ^a   Kadota, Yoshihisa ^a   Ohta, Mitsunori ^a   Matsuda, Hikaru ^a   Okumura, Meinoshin ^b   Eimoto, Tadaaki ^c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Glucocorticoid; Glucocorticoid receptor; Thymic epithelial cell; Thymoma

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO SELECTION; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOMA; TUMOR CELL; WORLD HEALTH ORGANIZATION;

ADULT; AGED; APOPTOSIS; CELL CYCLE; FEMALE; G1 PHASE; GLUCOCORTICOIDS; HUMANS; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; NEOPLASM STAGING; THYMOMA; THYMUS NEOPLASMS;

EID: 17644405438     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0646-8     Document Type: Article

References (38)

1. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosupression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290
2. Beato M, Herrlich P, Schutz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
3. Berki T, Kumanovics G, Kumanovics A, Falus A, Ujhelyi E, Nemeth P (1998) Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody. J Immunol Methods 214:19-27
4. Berki T, Palinkas L, Boldizsar F, Nemeth P (2002) Glucocorticoid (GC) sensitivity and GC receptor expression differ in thymocyte subpopulations. Int Immunol 14:463-469
5. Cohen JJ, Duke RC (1984) Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132:38-42
6. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9:1608-1621
7. Corroyer S, Nabeyrat E, Clement A (1997) Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids. Endocrinology 138:3677-3685
8. Florian RG, Michael K (2004) The IKK/NF-κB activation pathway - a terget for prevention and treatment of cancer. Cancer Lett 206:193-199
9. Gilhus NE, Jones M, Turley H, Gatter KC, Nagvekar N, Newsom-Davis J, Willcox N (1995) Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor and Ki67 antigen. J Clin Pathol 48:447-455
10. Greenberg AK, Hu J, Basu S, Hay J, Reibman J, Yie TA, Tchou-Wong KM, Rom WN, Lee TC (2002) Glucocorticoide inhibit lung cancer cell growth through both the extracellular signal-related kinase patheway and cell cycle regulators. Am J Respir Cell Mo Biol 27:320-328
11. Grilli M, Chiu JJ, Lenardo MJ (1993) NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 143:1-62
12. Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H (2002) Proliferative activity and apoptosis in thymic epithelial neoplasms. Mod Pathol 15:1326-1332
13. Hu E, Levine J (1986) Chemotherapy of malignant thymoma. Case report and review of the literature. Cancer 57:1101-1104
14. + cells in vitro. Clin Exp Immunol 112:419-426
15. Inoue M, Okumura M, Miyoshi S, Shiono H, Fukuhara K, Kadota Y, Shirakura R, Matsuda H (1999) Impaired expression of MHC class II molecules in response to interferon-gammna (INF-γ) on human thymoma neoplastic epithalial cells. Clin Exp Immunol 117:1-7
16. Kadota Y, Okumura M, Miyoshi S, Kitagawa-Sakakida S, Inoue M, Shiono H, Maeda Y, Kinoshita T, Shirakura R, Matsuda H (2000) Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-γ). Clin Exp Immunol 121:59-68
17. Karin M (1998) New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93:487-490
18. Levine GD, Rosai J (1978) Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9:495-515
19. Loehrer PJ Sr, Wang W, Johnson DH, Aisner SC, Ettinger DS (2004) Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 22:293-299
20. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485-2492
21. Masuda A, Ohtsuka K, Matsuyama M (1990) Establishment of functional epithelial cell lines from a rat thymoma and a rat thymus. In Vitro Cell Dev Biol 26:713-721
22. Müller-Hermelink HK, Marino M, Palestro G, Schumacher U, Kirchner T (1985) Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A 408:143-161
23. Palmieri G, Lastoria S, Colao A, Vergara E, Varrella P, Biondi E, Selleri C, Catalano L, Lombardi G, Bianco AR, Salvatore M (1997) Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 23:263-265
24. Pan CC, Chen PC, Wang LS, Lee JY, Chiang H (2003) Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours. Histopathology 43:165-172
25. Ramdas J, Liu W, Harmon JM (1999) Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Cancer Res 59:1378-1385
26. Rogatsky I, Hittelman AB, Pearce D, Garabedian MJ (1999) Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids. Mol Cell Biol 19:5036-5049
27. Rosai J, Sobin LH (1999) Histological typing of tumors of the thymus. International histological classification of tumors, 2nd edn. Springer, Heidelberg Berlin New York
28. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995a) Role of transcriptional activation of IκBα in mediation of immunosupression by glucocorticoids. Science 270:283-286
29. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr (1995b) Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 15:943-953
30. Soffer LJ, Gabrilove JL, Wolf BS (1952) Effect of ACTH on thymic masses. J Clin Endocrinol Metab 12:690-696
31. Tateyama H, Takahashi E, Saito Y, Fukai I, Fujii Y, Niwa H, Eimoto T (2001) Histopathologic changes of thymoma preoperatively treated with corticosteroids. Virchows Arch 438: 238-247
32. Termeer A, Visser FJ, Mravunac M (2001) Regression of invasive thymoma following corticosteroid therapy. Neth J Med 58:181-184
33. Wang CY, Mayo MW, Korneluk RC, Goeddel DV, Baldwin AS Jr (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1and C-IAP2 to suppress caspase-8 activation. Science 281:1680-1683
34. Wang W, Wykrzykowska J, Johnson T, Sen R, Sen J (1999) A NF-κB/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes. J Immunol 162:314-322
35. low thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol 31:2293-2301
36. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation. Nature 284:555-556
37. Yamamoto KR (1985) Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19:209-252
38. Young IT (1977) Proof without prejudice: use of the Kolmogorov-Smirnov test for analysis of histograms from flow systems and other sources. J Histochem Cytochem 25:935-941